274 related articles for article (PubMed ID: 25888031)
1. New echinocandin susceptibility patterns for nosocomial Candida albicans in Bogotá, Colombia, in ten tertiary care centres: an observational study.
Rodríguez-Leguizamón G; Fiori A; Lagrou K; Gaona MA; Ibáñez M; Patarroyo MA; Van Dijck P; Gómez-López A
BMC Infect Dis; 2015 Feb; 15():108. PubMed ID: 25888031
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
[TBL] [Abstract][Full Text] [Related]
4. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
6. Study of strains of Candida spp. Isolated from catheters in UHC of Oran (Algeria): Identification and antifungal susceptibility.
Bendjelloul M; Boucherit-Otmani Z; Boucherit K
J Mycol Med; 2016 Sep; 26(3):212-6. PubMed ID: 27103075
[TBL] [Abstract][Full Text] [Related]
7. Caspofungin-non-susceptible Candida isolates in cancer patients.
Kofteridis DP; Lewis RE; Kontoyiannis DP
J Antimicrob Chemother; 2010 Feb; 65(2):293-5. PubMed ID: 20016020
[TBL] [Abstract][Full Text] [Related]
8. Rapid development of Candida krusei echinocandin resistance during caspofungin therapy.
Forastiero A; Garcia-Gil V; Rivero-Menendez O; Garcia-Rubio R; Monteiro MC; Alastruey-Izquierdo A; Jordan R; Agorio I; Mellado E
Antimicrob Agents Chemother; 2015 Nov; 59(11):6975-82. PubMed ID: 26324281
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological and clinical characteristics of nosocomial candidiasis in university hospitals in Cuiabá--Mato Grosso, Brazil.
Akeme Yamamoto AC; de Paula CR; Dias LB; Tadano T; Martins ÉR; Amadio JV; Hahn RC
Rev Iberoam Micol; 2012; 29(3):164-8. PubMed ID: 22285886
[TBL] [Abstract][Full Text] [Related]
10. Distribution of Candida species isolated from blood cultures in hospitals in Osaka, Japan.
Morii D; Seki M; Binongo JN; Ban R; Kobayashi A; Sata M; Hashimoto S; Shimizu J; Morita S; Tomono K
J Infect Chemother; 2014 Sep; 20(9):558-62. PubMed ID: 25009091
[TBL] [Abstract][Full Text] [Related]
11. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
[TBL] [Abstract][Full Text] [Related]
13. Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
Colombo AL; Ngai AL; Bourque M; Bradshaw SK; Strohmaier KM; Taylor AF; Lupinacci RJ; Kartsonis NA
Antimicrob Agents Chemother; 2010 May; 54(5):1864-71. PubMed ID: 20231388
[TBL] [Abstract][Full Text] [Related]
14. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
[TBL] [Abstract][Full Text] [Related]
15. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro susceptibility of clinical isolates of Candida paparsilosis complex and other Candida species to caspofungin and anidulafungin by Etest.
Khan Z; Ahmad S; Joseph L; Chandy R; Theyyathel A
J Chemother; 2011 Apr; 23(2):97-101. PubMed ID: 21571626
[TBL] [Abstract][Full Text] [Related]
17. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
[TBL] [Abstract][Full Text] [Related]
18. [Adequate empiric therapy of nosocomial fungal infections in oncologic patients of intensive care units].
Mitrokhin SD; Fedankov IN; Khoteev AZh; Sokolov AA
Antibiot Khimioter; 2012; 57(3-4):40-4. PubMed ID: 22993939
[TBL] [Abstract][Full Text] [Related]
19. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
[TBL] [Abstract][Full Text] [Related]
20. Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
Liew YX; Teo J; Too IA; Ngan CC; Tan AL; Chlebicki MP; Kwa AL; Lee W
BMC Infect Dis; 2015 Jul; 15():256. PubMed ID: 26137997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
